%D8%A3%D8%B1%D8%A8%D9%8A%D9%83%D8%A7%D8%B3%D9%8A%D9%86Arbekacin%D8%A2%D8%B1%D8%A8%DA%A9%D8%A7%D8%B3%DB%8C%D9%86%E3%82%A2%E3%83%AB%E3%83%99%E3%82%AB%E3%82%B7%E3%83%B3ArbecacinaArbekacin%C4%83ArbekacinArbekacin%E0%B8%AD%E0%B8%B2%E0%B8%A3%E0%B9%8C%E0%B8%9A%E0%B8%B5%E0%B8%81%E0%B8%B2%E0%B8%8B%E0%B8%B4%E0%B8%99ArbekacinQ4784668
about
Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant BacteriaPharmacokinetics and Safety Study of ME1100 in Healthy VolunteersA Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial PneumoniaPhase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy
P4844
Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms.Population pharmacokinetics of arbekacin in burn patients.A proof of the specificity of kanamycin-ribosomal RNA interaction with designed synthetic analogs and the antibacterial activity
P921
Q33555775-9871D24E-BEC2-47FD-9E86-BB632797DF7BQ34510589-E5ACC1ED-DA0E-4C71-9644-7A17BF5B4AC4Q35647670-792E8B57-5BC0-44AC-8088-A00CE247DE2FQ36702959-9428AC9C-DD08-4CC8-A71A-4394EC44E3D2Q40622327-81D6745D-372A-4E60-9953-DAB1E698B43BQ46718647-17E4B2A0-06EB-4658-8AA1-B8987C342991Q81610300-7B0A6401-2DA7-4BD0-A472-57D542DC7B74
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Arbekacin
@sh
Arbekacin
@sr
Arbekacin
@vi
Arbekacină
@ro
arbecacina
@pt
arbekacin
@en
آربکاسین
@fa
أربيكاسين
@ar
อาร์บีกาซิน
@th
アルベカシン
@ja
type
label
Arbekacin
@sh
Arbekacin
@sr
Arbekacin
@vi
Arbekacină
@ro
arbecacina
@pt
arbekacin
@en
آربکاسین
@fa
أربيكاسين
@ar
อาร์บีกาซิน
@th
アルベカシン
@ja
altLabel
ABK
@en
ABK
@ja
Arbekacin
@en
Arbekacina
@en
Arbekacine
@en
Arbekacinum
@en
Habekacin
@en
Haberacin
@en
NPC-14
@en
arbekacin sulfate
@en
prefLabel
Arbekacin
@sh
Arbekacin
@sr
Arbekacin
@vi
Arbekacină
@ro
arbecacina
@pt
arbekacin
@en
آربکاسین
@fa
أربيكاسين
@ar
อาร์บีกาซิน
@th
アルベカシン
@ja
P31
P486
P592
P6366
P661
P662
P665
P683
P117
P1579
P1748
P2017
NCC[C@H](O)C(=O)N[C@@H]1C[C@H] ...... H](CO)[C@@H](O)[C@H](N)[C@H]3O
P2067
P2275
arbekacin
@en
P231
51025-85-5
P233
C1CC(C(OC1CN)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CO)O)N)O)NC(=O)C(CCN)O)N)N